High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium

Investigative Radiology

Volumn 43, Issue 11, 2008, Pages 809-815

  Asbach, Patrick ^a   Warmuth, Carsten ^b   Stemmer, Alto ^b   Rief, Matthias ^a   Huppertz, Alexander ^a   Hamm, Bernd ^a   Taupitz, Matthias ^a   Klessen, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

Hepatobiliary imaging; Liver specific contrast media; Respiratory triggered T1 weighted imaging

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; GADOLINIUM ETHOXYBENZYL DTPA; GADOLINIUM PENTETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE QUALITY; LIVER INJURY; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; HEPATOBILIARY SYSTEM; IMAGE ENHANCEMENT; LIVER; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 58149288346     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318186242b     Document Type: Article

References (21)

1. Namkung S, Zech CJ, Helmberger T, et al. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: effcacy for characterization of focal liver lesions. J Magn Reson Imaging. 2007;25:755-765.
2. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2007;18:457-467.
3. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology. 2005;234:468-478.
4. Pavone P, Laghi A, Panebianco V, et al. MR cholangiography: techniques and clinical applications. Eur Radiol. 1998;8:901-910.
5. Asbach P, Klessen C, Kroencke TJ, et al. Magnetic resonance cholangiopancreatography using a free-breathing T2-weighted turbo spin-echo sequence with navigator-triggered prospective acquisition correction. Magn Reson Imaging. 2005;23:939-945.
6. Holzapfel K, Breitwieser C, Prinz C, et al. Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA. Preliminary experience and clinical applications [in German]. Radiologe. 2007;47:536-544.
7. Hamm B, Staks T, Mühler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995;195:785-792.
8. Bollow M, Taupitz M, Hamm B, et al. Gadolinium ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol. 1997;7:126-132.
9. Lee SS, Byun JH, Hong HS, et al. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging. 2007;26:323-330.
10. Rodenwaldt J, Kopka L, Meyer HJ, et al. Determination of contour clarity in contrast-enhanced MR angiography: definition and clinical evaluation exemplified by ECG-triggered imaging of the thoracic aorta [in German]. Rofo. 1998;169:616-621.
11. Dietrich O, Raya JG, Reeder SB, et al. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging. 2007;26: 375-385.
12. Tsuda N, Okada M, Murakami T. Potential of gadolinium- ethoxybenzyldiethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of non-alcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol. 2007;42:242-247.
13. Dahlström N, Persson A, Albiin N, et al. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol. 2007;48:362-368.
14. Döhr O, Hofmeister R, Treher M, et al. Preclinical safety evaluation of Gd-EOB-DTPA (Primovist). Invest Radiol. 2007;42:830-841.
15. Klessen C, Asbach P, Kroencke TJ, et al. Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correction. J Magn Reson Imaging. 2005;21:576-582.
16. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using respiratory triggered diffusionweighted single-shot echo-planar MR imaging technique. Eur Radiol. 2008;18:477-485.
17. Sasaki K, Ito K, Fujita T, et al. Small hepatic lesions found on single-phase helical CT in patients with malignancy: diagnostic capability of breath-hold, multisection fluid-attenuated inversion-recovery (FLAIR) MR imaging using a half-fourier acquisition single-shot turbo spin-echo (HASTE) sequence. J Magn Reson Imaging. 2007;25:129-136.
18. Kim JI, Lee JM, Choi JY, et al. The value of gadobenate dimeglumineenhanced delayed phase MR imaging for characterization of hepatic nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-210.
19. Schneider G, Altmeyer K, Kirchin MA, et al. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging. Invest Radiol. 2007;42:105-115.
20. Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted, gradient echo sequence - initial experience in the brain. Radiology. 1992; 182:769-775.
21. Zech CJ, Herrmann KA, Dietrich O, et al. Black-blood diffusionweighted EPI acquisition of the liver with parallel imaging: comparison with standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol. 2008;43:261-266.